Aziskil 250mg Tablet

Introduction

Aziskil is a prescription medication that combines two active ingredients, Miconazole and Mometasone. It is available in tablet form and is primarily used for the treatment of certain fungal infections and inflammatory skin conditions.

Uses

Aziskil is commonly prescribed for the following conditions:

• Fungal infections: It is effective in treating fungal infections of the skin, such as athlete’s foot, jock itch, and ringworm.
• Inflammatory skin conditions: It can also be used to alleviate symptoms of inflammatory skin conditions, such as dermatitis and eczema.

Dosage and Administration

The dosage and administration of Aziskil should be determined by a healthcare professional, as it may vary depending on the specific condition being treated. It is typically taken orally, with or without food. Follow the instructions provided by your healthcare provider or refer to the product label for the recommended dosage.

Mechanism of Action

Aziskil contains two active ingredients: Miconazole and Mometasone. Miconazole is an antifungal agent that works by inhibiting the growth of fungi, thereby treating fungal infections. Mometasone is a corticosteroid that helps reduce inflammation and itching associated with certain skin conditions.

Side Effects

Common side effects may include itching, redness, burning, or stinging at the application site. These side effects are usually mild and temporary.

However, if you experience any serious side effects such as severe allergic reactions, skin thinning, or changes in skin color, seek medical attention immediately. Report any unusual or persistent side effects to your healthcare provider.

Drug Interactions

Aziskil may interact with certain medications, including other antifungal agents or corticosteroids. Inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. They can assess any potential interactions and adjust your treatment plan accordingly.

Precautions

Before using Aziskil, inform your healthcare provider about any existing medical conditions, allergies, or medications you are taking. This medication may not be suitable for individuals with certain conditions, such as hypersensitivity to any of the ingredients or active substances.

Avoid contact with the eyes when applying Aziskil. If accidental eye contact occurs, rinse thoroughly with water and seek medical advice if needed.

Storage

Aziskil should be stored at room temperature, away from moisture and heat. Keep it out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

Here are some tips to help you make the most of your treatment with Aziskil:

• Follow the instructions provided by your healthcare provider or refer to the product label regarding the dosage and administration of the medication.
• If you experience any side effects, even if they seem mild, consult your healthcare provider.
• Avoid using the medication for longer than recommended or in larger amounts than prescribed.
• If your symptoms do not improve or worsen after using Aziskil, contact your healthcare provider.
• Remember to store the medication properly to maintain its effectiveness.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mometasone nasal spray: a medicine to treat allergic rhinitis and hay fever (NHS UK) [Accessed 5 Jun. 2024] (online) Available at:
• Daktacort 2% / 1% w/w cream (Health Professionals SmPC) Available at:
• Miconazole oral buccal (Drugs.com) [Accessed 0 Jun. 2024] (online) Available at:
• miconazole nitrate-dimeth-znox spray, non-aerosol (OTC) [Accessed 4 Jun. 2024] (online) Available at:
• Miconazole Topical (MedlinePlus) [Accessed 30 Jun. 2024] (online) Available at:
• Levine HB. Miconazole in coccidioidomycosis. Proc R Soc Med. 1977;70 Suppl 1(Suppl 1):13-7. [Accessed 7 Jun. 2024] Available at: